PDL BIOPHARMA, INC. - 69329Y104

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$1K
QoQ value delta ($000)
-$27K (-96.43%)
Implied price effect (QoQ)
-95.46%
Shares
Total shares
42,805
QoQ shares delta
-11,554 (-21.25%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
RHUMBLINE ADVISERS 1 612 0.0%
Financial Gravity Companies, Inc. 0 13 0.0%
Westside Investment Management, Inc. 0 500 0.0%
Argent Trust Co 0 41,405 0.0%
WELLINGTON-ALTUS USA INC. 0 275 0.0%